Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Natural antibodies sustain differentiation and maturation of human dendritic cells
Jagadeesh Bayry *,
Sébastien Lacroix-Desmazes *,
Vladimira Donkova-Petrini *,
Cédric Carbonneil *,
Namita Misra *,
Yves Lepelletier,
Sandrine Delignat *,
Sooryanarayana Varambally *,,
Eric Oksenhendler,
Yves Lévy ¶,
Marianne Debré ||,
Michel D. Kazatchkine *,
Olivier Hermine, and
Srini V. Kaveri *, **
*Institut National de la Santé et de la Recherche Médicale Unité 430 and Université Pierre et Marie Curie, Institut des Cordeliers, 75006 Paris, France; Department of Hematology and Centre National de la Recherche Scientifique-Unité Mixte de Recherche 8603, Hôpital Necker-Enfants-Malades, 75015 Paris, France; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; Department of Clinical Immunopathology, Hôpital Saint Louis, 75010 Paris, France; ¶Service d'Immunologie Clinique, Hôpital Henri Mondor, 94010 Créteil Cedex, France; and ||Institut National de la Santé et de la Recherche Médicale Unité 429, Hôpital Necker-Enfants-Malades, 75015 Paris, France
Edited by Ralph M. Steinman, The Rockefeller University, New York, NY, and approved July 1, 2004
Received for publication March 29, 2004.
Abstract:
The differentiation and maturation of dendritic cells (DCs)is governed by various signals in the microenvironment. Monocytesand DCs circulate in peripheral blood, which contains high levelsof natural antibodies (NAbs). NAbs are germ-line-encoded andoccur in the absence of deliberate immunization or microbialaggression. To assess the importance of NAbs in the milieu onDC development, we examined the status of DCs in patients withX-linked agammaglobulinemia, a disease characterized by paucityof B cells and circulating antibodies. We demonstrate that thein vitro differentiation of DCs is severely impaired in thesepatients, at least in part because of low levels of circulatingNAbs. We identified NAbs reactive with the CD40 molecule asan important component that participates in the developmentof DCs. CD40-reactive NAbs restored normal phenotypes of DCsin patients. The maturation process induced by CD40-reactiveNAbs was accompanied by an increased IL-10 and decreased IL-12production. The transcription factor analysis revealed distinctsignaling pathways operated by CD40-reactive NAbs compared tothose by CD40 ligand. These results suggest that B cells promotebystander DC development through NAbs and the interaction betweenNAbs and DCs may play a role in steady-state migration of DCs.
This paper was submitted directly (Track II) to the PNAS office.
** To whom correspondence should be addressed at: Institut National de la Santé et de la Recherche Médicale Unité 430, Institut des Cordeliers, 15 Rue de l'Ecole de Médecine, 75006 Paris, France. E-mail: srini.kaveri{at}u430.bhdc.jussieu.fr.
Natural Antibody Contributes to Host Defense against an Attenuated Brucella abortus virB Mutant.
H. G. Rolan, M. N. Xavier, R. L. Santos, and R. M. Tsolis (2009)
Infect. Immun.
77, 3004-3013
|Abstract »|Full Text »|PDF »
Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack.
M. J. Szczepanski, M. Czystowska, M. Szajnik, M. Harasymczuk, M. Boyiadzis, A. Kruk-Zagajewska, W. Szyfter, J. Zeromski, and T. L. Whiteside (2009)
Cancer Res.
69, 3105-3113
|Abstract »|Full Text »|PDF »
DC-SIGN and {alpha}2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells.
J. Bayry, K. Bansal, M. D. Kazatchkine, and S. V. Kaveri (2009)
PNAS
106, E24
|Full Text »|PDF »
IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via Fc{gamma}RIIa.
A. Smed-Sorensen, M. Moll, T.-Y. Cheng, K. Lore, A.-C. Norlin, L. Perbeck, D. B. Moody, A.-L. Spetz, and J. K. Sandberg (2008)
Blood
111, 5037-5046
|Abstract »|Full Text »|PDF »
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.
A. Ephrem, S. Chamat, C. Miquel, S. Fisson, L. Mouthon, G. Caligiuri, S. Delignat, S. Elluru, J. Bayry, S. Lacroix-Desmazes, et al. (2008)
Blood
111, 715-722
|Abstract »|Full Text »|PDF »
Natural Antibodies Related to Energy Balance in Early Lactation Dairy Cows.
A. T. M. van Knegsel, G. de Vries Reilingh, S. Meulenberg, H. van den Brand, J. Dijkstra, B. Kemp, and H. K. Parmentier (2007)
J Dairy Sci
90, 5490-5498
|Abstract »|Full Text »|PDF »
Natural Humoral Immune Competence and Survival in Layers.
L. Star, K. Frankena, B. Kemp, M. G. B. Nieuwland, and H. K. Parmentier (2007)
Poult. Sci.
86, 1090-1099
|Abstract »|Full Text »|PDF »
Sialylated therapeutic IgG: a sweet remedy for inflammatory diseases?.
J. D. Dimitrov, J. Bayry, S. Siberil, and S. V. Kaveri (2007)
Nephrol. Dial. Transplant.
22, 1301-1304
|Full Text »|PDF »
Therapeutic Efficacy of High-Dose Intravenous Immunoglobulin in Mycobacterium tuberculosis Infection in Mice.
E. Roy, E. Stavropoulos, J. Brennan, S. Coade, E. Grigorieva, B. Walker, B. Dagg, R. E. Tascon, D. B. Lowrie, M. J. Colston, et al. (2005)
Infect. Immun.
73, 6101-6109
|Abstract »|Full Text »|PDF »
Modulation of Dendritic Cell Maturation and Function by B Lymphocytes.
J. Bayry, S. Lacroix-Desmazes, M. D. Kazatchkine, O. Hermine, D. F. Tough, and S. V. Kaveri (2005)
J. Immunol.
175, 15-20
|Abstract »|Full Text »|PDF »